Bosl, George

Publications

Sort by

Co-Author Network

selected publications

Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 8
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 16
Time to publication of oncology trials and why some trials are never published. PloS one. 2017 Academic Article GET IT
Times cited: 18
Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Times cited: 47
How We Care for an Older Patient With Cancer. 2017 GET IT
Times cited: 40
Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy. Urology. 2016 Academic Article GET IT
Times cited: 8
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors. The Journal of urology. 2016 Academic Article GET IT
Times cited: 6
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 121
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach. Oncology (Williston Park, N.Y.). 2016 Review GET IT
Times cited: 10
Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience. Urology. 2016 Academic Article GET IT
Times cited: 3
Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 29
Recurrent Germ Cell Tumors: Let's Try to Cure Them All. Journal of oncology practice. 2016 Comment GET IT
Times cited: 3
Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification. Stem cell reports. 2016 Academic Article GET IT
Times cited: 7
Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach. PloS one. 2015 Academic Article GET IT
Times cited: 16
Development of a risk stratification system to guide treatment for female germ cell tumors. Gynecologic oncology. 2015 Academic Article GET IT
Times cited: 28
Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors. Clinical genitourinary cancer. 2015 Academic Article GET IT
Times cited: 7
Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 30
Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency. Stem cells (Dayton, Ohio). 2015 Academic Article GET IT
Times cited: 21
Germ cell tumors: looking to the future. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2015 Academic Article GET IT
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors. The Journal of urology. 2014 Academic Article GET IT
Times cited: 16
Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 79
miR-18b and miR-518b Target FOXN1 during epithelial lineage differentiation in pluripotent cells. Stem cells and development. 2014 Academic Article GET IT
Times cited: 12
Clinical outcomes of local and metastatic testicular sex cord-stromal tumors. The Journal of urology. 2014 Academic Article GET IT
Times cited: 38
Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy. Urology. 2013 Academic Article GET IT
Times cited: 17
Reply: To PMID 24094653. Urology. 2013 Comment GET IT
Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older. Cancer. 2013 Academic Article GET IT
Times cited: 29
Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition. PloS one. 2012 Academic Article GET IT
Times cited: 73
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 201
Rare de novo germline copy-number variation in testicular cancer. American journal of human genetics. 2012 Academic Article GET IT
Times cited: 16
Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site. Urology. 2012 Academic Article GET IT
Times cited: 6
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour. BJU international. 2012 Academic Article GET IT
Times cited: 8
Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer. Urology. 2012 Academic Article GET IT
Times cited: 22
Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection. Urology. 2011 Academic Article GET IT
Times cited: 16
Misunderstanding regarding the carboplatin dose comparison in MRC TE19/EORTC 30982. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Letter GET IT
Times cited: 1
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design. Cancer. 2011 Academic Article GET IT
Times cited: 51
Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2011 Academic Article GET IT
Times cited: 38
A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors. Hematology/oncology clinics of North America. 2011 Review GET IT
Times cited: 12
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update. Urology. 2011 Academic Article GET IT
Times cited: 11
Carboplatin in clinical stage I seminoma: too much and too little at the same time. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Editorial Article GET IT
Times cited: 20
CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology. 2011 Review GET IT
Times cited: 134
Contemporary lymph node counts during primary retroperitoneal lymph node dissection. Urology. 2010 Academic Article GET IT
Times cited: 12
Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy. Cancer. 2010 Academic Article GET IT
Times cited: 8
Evaluation of lymph node counts in primary retroperitoneal lymph node dissection. Cancer. 2010 Academic Article GET IT
Times cited: 24
The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer. Urology. 2010 Academic Article GET IT
Times cited: 40
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 176
Weighing risks and benefits of postchemotherapy retroperitoneal lymph node dissection: not so easy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Editorial Article GET IT
Times cited: 15
Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 48
Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin. BJU international. 2009 Review GET IT
Times cited: 23
Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 66
Testicular granulosa cell tumors: rare tumors need to be studied too. Oncology (Williston Park, N.Y.). 2009 Comment GET IT
Times cited: 1
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors. Investigational new drugs. 2009 Academic Article GET IT
Times cited: 67
Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2009 Academic Article GET IT
Times cited: 62
Treatment of stage I seminoma: is it time to change your practice?. Journal of hematology & oncology. 2008 Academic Article GET IT
Times cited: 14
Clinical outcome and predictors of survival in late relapse of germ cell tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 79
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 5
The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor. Cancer. 2008 Academic Article GET IT
Times cited: 19
Medical treatment of advanced testicular cancer. JAMA. 2008 Review GET IT
Times cited: 293
In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes, chromosomes & cancer. 2008 Academic Article GET IT
Times cited: 47
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 98
Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 74
Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 117
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors. Investigational new drugs. 2007 Academic Article GET IT
Times cited: 21
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour. BJU international. 2007 Academic Article GET IT
Times cited: 27
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. The Journal of urology. 2007 Academic Article GET IT
Times cited: 83
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer. 2007 Academic Article GET IT
Times cited: 56
Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 80
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 300
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 108
Advances in urologic oncology: results progress from successful interdisciplinary research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Article GET IT
Times cited: 1
Biology and genetics of adult male germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 70
Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem cells (Dayton, Ohio). 2006 Academic Article GET IT
Times cited: 11
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection. The Journal of urology. 2006 Academic Article GET IT
Times cited: 63
Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer research. 2006 Academic Article GET IT
Times cited: 255
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer journal (Sudbury, Mass.). 2006 Academic Article GET IT
Times cited: 33
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 95
Carboplatin for stage I seminoma and the sword of Damocles. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Editorial Article GET IT
Times cited: 21
Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 71
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 327
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. The Journal of urology. 2005 Academic Article GET IT
Times cited: 91
Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene. 2005 Academic Article GET IT
Times cited: 50
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 168
Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. Functional & integrative genomics. 2005 Academic Article GET IT
Times cited: 22
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors. Molecular cancer. 2004 Academic Article GET IT
Times cited: 128
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors. Investigational new drugs. 2004 Academic Article GET IT
Times cited: 12
Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 75
Chemotherapy for teratoma with malignant transformation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 175
Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma. Urology. 2003 Review GET IT
Times cited: 30
Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors. The Journal of urology. 2003 Academic Article GET IT
Times cited: 47
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome. Urology. 2003 Academic Article GET IT
Times cited: 77
Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis. The Journal of urology. 2003 Academic Article GET IT
Times cited: 19
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 21
Characteristic promoter hypermethylation signatures in male germ cell tumors. Molecular cancer. 2002 Academic Article GET IT
Times cited: 82
Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes. Cancer research. 2002 Academic Article GET IT
Times cited: 45
The future of therapy for nonseminomatous germ cell tumors. Chest surgery clinics of North America. 2002 Review GET IT
Times cited: 3
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. The American journal of pathology. 2002 Academic Article GET IT
Times cited: 77
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 61
Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 2002 Academic Article GET IT
Times cited: 53
Salvage chemotherapy for patients with advanced pure seminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 51
Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features. International journal of surgical pathology. 2002 Academic Article GET IT
Times cited: 73
Expression of ID genes in differentiated elements of human male germ cell tumors. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 2001 Academic Article GET IT
Times cited: 3
A method for assessing house staff workload as a function of length of stay. JAMA. 2001 Letter GET IT
Times cited: 12
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 121
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 90
ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines. Cell and tissue research. 2001 Academic Article GET IT
Times cited: 19
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 82
Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors. Investigational new drugs. 2000 Academic Article GET IT
Times cited: 12
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 235
Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. 2000 GET IT
Times cited: 41
Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 165
High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: the Memorial Sloan-Kettering experience (1988-1999). International journal of cancer. 1999 Academic Article GET IT
Times cited: 19
Germ cell tumor clinical trials in North America. Seminars in surgical oncology. 1999 Review GET IT
Times cited: 8
Telomerase activity in germ cell cancers and mature teratomas. Journal of the National Cancer Institute. 1999 Academic Article GET IT
Times cited: 51
A 3-Mb high-resolution BAC/PAC contig of 12q22 encompassing the 830-kb consensus minimal deletion in male germ cell tumors. Genome research. 1999 Academic Article GET IT
Times cited: 20
Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. Journal of the National Cancer Institute. 1999 Editorial Article GET IT
Times cited: 33
Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. The Annals of thoracic surgery. 1998 Academic Article GET IT
Times cited: 79
Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. Cancer research. 1998 Academic Article GET IT
Times cited: 87
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck. Head & neck. 1998 Academic Article GET IT
Times cited: 49
FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas. Oncogene. 1998 Academic Article GET IT
Times cited: 28
Recurrence of the mediastinal growing teratoma syndrome. The Annals of thoracic surgery. 1998 Letter GET IT
Times cited: 6
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene. 1998 Academic Article GET IT
Times cited: 136
Germ cell tumors: there is still plenty to learn. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Editorial Article GET IT
Clinical stage I testis cancer: long-term outcome of patients on surveillance. The Journal of urology. 1998 Academic Article GET IT
Times cited: 134
Medical and surgical management of pulmonary metastases from germ cell tumors. Chest surgery clinics of North America. 1998 Review GET IT
Times cited: 8
Metastatic germ cell tumors: modeling for response to chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 24
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. 1998 GET IT
Times cited: 322
Implementation of practice guidelines. Oncology (Williston Park, N.Y.). 1997 Academic Article GET IT
Times cited: 1
Combined-modality therapy for bladder cancer. Oncology (Williston Park, N.Y.). 1997 Review GET IT
Times cited: 4
Mediastinal growing teratoma syndrome. 1997 GET IT
Times cited: 51
Testicular germ-cell cancer. The New England journal of medicine. 1997 Review GET IT
Times cited: 770
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 156
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 163
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 66
Bleomycin in germ cell tumor therapy: not all regimens are created equal. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Editorial Article GET IT
Times cited: 15
Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 148
Surgery for a post-chemotherapy residual mass in seminoma. The Journal of urology. 1997 Review GET IT
Times cited: 137
Germ cell tumors. Current therapy in endocrinology and metabolism. 1997 Review GET IT
Times cited: 1
Development and implementation of clinical management guidelines. Oncology (Williston Park, N.Y.). 1996 Academic Article GET IT
Times cited: 3
Physical mapping of a commonly deleted region, the site of a candidate tumor suppressor gene, at 12q22 in human male germ cell tumors. Genomics. 1996 Academic Article GET IT
Times cited: 29
Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors. Oncogene. 1996 Academic Article GET IT
Times cited: 29
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 81
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 173
Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 152
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head & neck. 1996 Academic Article GET IT
Times cited: 90
Salvage laryngectomy for unsuccessful larynx preservation therapy. The Annals of otology, rhinology, and laryngology. 1995 Academic Article GET IT
Times cited: 32
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 62
Germ cell tumors: unraveling a biological paradox. Laboratory investigation; a journal of technical methods and pathology. 1995 Editorial Article GET IT
Times cited: 6
all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial. Cancer. 1995 Academic Article GET IT
Times cited: 29
Paclitaxel in germ cell cancer. Seminars in oncology. 1995 Review GET IT
Times cited: 26
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 107
Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors. Investigational new drugs. 1995 Academic Article GET IT
Times cited: 28
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 30
Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer research. 1994 Academic Article GET IT
Times cited: 68
Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene. 1994 Academic Article GET IT
Times cited: 46
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 186
The management of patients with advanced germ cell tumors. Seminoma and nonseminoma. The Urologic clinics of North America. 1994 Review GET IT
Times cited: 8
Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. Journal of the National Cancer Institute. 1994 Academic Article GET IT
Times cited: 483
Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison. Seminars in oncology. 1994 Academic Article GET IT
Times cited: 13
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer. 1994 Academic Article GET IT
Times cited: 93
Allelic loss and somatic differentiation in human male germ cell tumors. Oncogene. 1994 Academic Article GET IT
Times cited: 82
Replication error-type genetic instability at 1q42-43 in human male germ cell tumors. Cancer research. 1994 Academic Article GET IT
Times cited: 47
Loss of heterozygosity and decreased expression of NME genes correlate with teratomatous differentiation in human male germ cell tumors. Biochemical and biophysical research communications. 1994 Academic Article GET IT
Times cited: 10
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 141
The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy. The Journal of urology. 1994 Academic Article GET IT
Times cited: 69
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay. Cancer. 1994 Academic Article GET IT
Times cited: 32
The use of tumor markers in germ cell malignancies. Hematology/oncology clinics of North America. 1994 Review GET IT
Times cited: 10
Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy. Cancer. 1994 Academic Article GET IT
Times cited: 65
Clinical relevance of the i(12p) marker chromosome in germ cell tumors. Journal of the National Cancer Institute. 1994 Academic Article GET IT
Times cited: 114
After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 60
Bladder cancer: advances in biology and treatment. Critical reviews in oncology/hematology. 1994 Review GET IT
Times cited: 8
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 138
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer. Archives of otolaryngology--head & neck surgery. 1994 Academic Article GET IT
Times cited: 35
Germ cell tumors. Current therapy in endocrinology and metabolism. 1994 Academic Article GET IT
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation. Skull base surgery. 1994 Academic Article GET IT
Serum tumor marker half-life during chemotherapy in patients with germ cell tumors. The International journal of biological markers. 1994 Academic Article GET IT
Times cited: 11
Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes, chromosomes & cancer. 1993 Academic Article GET IT
Times cited: 135
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 148
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. Cancer research. 1993 Academic Article GET IT
Times cited: 48
Intracardiac teratoma 15 years after treatment of a nonseminomatous germ cell tumor. 1993 GET IT
Times cited: 13
The management of the clinically positive neck as part of a larynx preservation approach. International journal of radiation oncology, biology, physics. 1993 Review GET IT
Times cited: 55
Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site. Seminars in oncology. 1993 Review GET IT
Times cited: 40
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer. Investigational new drugs. 1993 Academic Article GET IT
Times cited: 4
Cytogenetics of male germ-cell tumors. The Urologic clinics of North America. 1993 Review GET IT
Times cited: 65
Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumors. The Urologic clinics of North America. 1993 Review GET IT
Times cited: 17
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 112
Chemotherapy of germ cell tumors: current status and future directions. European urology. 1993 Review GET IT
Times cited: 2
Prognostic factors for metastatic testicular germ cell tumours: the Memorial Sloan-Kettering cancer model. European urology. 1993 Review GET IT
Times cited: 12
The current status of salvage chemotherapy for patients with cisplatin-resistant germ cell tumors. Cancer investigation. 1993 Editorial Article GET IT
Times cited: 2
The evolving role of chemotherapy of germ cell tumors. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1993 Review GET IT
Times cited: 1
A pilot study of immunization with interleukin-2 secreting allogeneic HLA-A2 matched renal cell carcinoma cells in patients with advanced renal cell carcinoma. Human gene therapy. 1992 Academic Article GET IT
Times cited: 27
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. The Journal of urology. 1992 Academic Article GET IT
Times cited: 83
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. Seminars in oncology. 1992 Academic Article GET IT
Times cited: 29
High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions. Journal of the National Cancer Institute. 1992 Review GET IT
Times cited: 84
Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proceedings of the National Academy of Sciences of the United States of America. 1992 Academic Article GET IT
Times cited: 106
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer research. 1992 Academic Article GET IT
Times cited: 110
Phase II study of iproplatin (CHIP) in patients with cisplatin-refractory germ cell tumors; the need for alternative strategies in the investigation of new agents in GCT. Investigational new drugs. 1992 Academic Article GET IT
Times cited: 11
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer. 1992 Academic Article GET IT
Times cited: 91
The late effects of germ cell tumor chemotherapy: more data are needed. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Editorial Article GET IT
Times cited: 4
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 70
Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization. Genes, chromosomes & cancer. 1992 Academic Article GET IT
Times cited: 37
"Poor-risk" germ cell tumors: current progress and future directions. Seminars in oncology. 1992 Review GET IT
Times cited: 26
Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Seminars in oncology. 1992 Review GET IT
Times cited: 60
The genetic and biologic aspects of treatment response and resistance in male germ cell cancer. Seminars in oncology. 1992 Review GET IT
Times cited: 15
Current status of larynx preservation with multimodality therapy. Oncology (Williston Park, N.Y.). 1992 Academic Article GET IT
Times cited: 18
Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha. Journal of the National Cancer Institute. 1992 Editorial Article GET IT
Times cited: 26
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer. 1991 Academic Article GET IT
Times cited: 89
Genetic analysis of germ cell tumors: current progress and future prospects. Hematology/oncology clinics of North America. 1991 Review GET IT
Times cited: 14
Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. International journal of radiation oncology, biology, physics. 1991 Academic Article GET IT
Times cited: 49
Detection and analysis of origin of i(12p), a diagnostic marker of human male germ cell tumors, by fluorescence in situ hybridization. Genes, chromosomes & cancer. 1991 Academic Article GET IT
Times cited: 55
Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features. Cancer. 1991 Academic Article GET IT
Times cited: 98
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. 1991 GET IT
Times cited: 64
Abnormalities of 2q: a common genetic link between rhabdomyosarcoma and hepatoblastoma?. Genes, chromosomes & cancer. 1991 Academic Article GET IT
Times cited: 61
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer. 1991 Academic Article GET IT
Times cited: 142
Serum tumor markers and patient allocation to good-risk and poor-risk clinical trials in patients with germ cell tumors. Cancer. 1991 Academic Article GET IT
Times cited: 20
Chemotherapy as part of the initial treatment for nasopharyngeal cancer. Oncology (Williston Park, N.Y.). 1991 Review GET IT
Times cited: 12
Analysis of chromosome 12 abnormalities in male germ cell cancers. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1991 Review GET IT
Times cited: 4
Assessment of risk in metastatic testis carcinoma: impact on treatment. Urologia internationalis. 1991 Review GET IT
Times cited: 4
BOMM: new solution or old problem?. Cancer investigation. 1991 Editorial Article GET IT
Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation. Important advances in oncology. 1991 Review GET IT
Times cited: 8
Continued refinement in the treatment of germ cell tumour patients. European journal of cancer (Oxford, England : 1990). 1991 Editorial Article GET IT
Times cited: 2
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors. European urology. 1991 Academic Article GET IT
Times cited: 14
Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. Journal of cancer research and clinical oncology. 1991 Academic Article GET IT
Times cited: 35
Two-drug therapy in patients with metastatic germ cell tumors. Cancer. 1991 Academic Article GET IT
Times cited: 29
Nonrandom chromosome abnormalities in testicular and ovarian germ cell tumor cell lines. Cancer genetics and cytogenetics. 1990 Academic Article GET IT
Times cited: 34
Phase II trial of Didemnin B in patients with advanced renal cell carcinoma. Investigational new drugs. 1990 Academic Article GET IT
Times cited: 14
Sarcoidosis, "Sarcoid-like lymphadenopathy," and testicular germ cell tumors. The American journal of medicine. 1990 Review GET IT
Times cited: 31
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors. Cancer research. 1990 Academic Article GET IT
Times cited: 132
The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients. Cancer. 1990 Academic Article GET IT
Times cited: 22
Decompression of epidural metastases from germ cell tumors with chemotherapy. 1990 GET IT
Times cited: 27
Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy. Radiology. 1990 Academic Article GET IT
Times cited: 32
Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation. Oncogene. 1990 Academic Article GET IT
Times cited: 37
Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. Journal of the National Cancer Institute. 1990 Academic Article GET IT
Times cited: 133
A review of the management of germ cell tumors: evolution of a curative treatment program. Cancer investigation. 1990 Review GET IT
Times cited: 3
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency. 1990 GET IT
Times cited: 37
Clinical and genetic features of human germ cell cancer. Cancer surveys. 1990 Review GET IT
Times cited: 14
Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction. Genes, chromosomes & cancer. 1990 Academic Article GET IT
Times cited: 36
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation. Progress in clinical and biological research. 1990 Academic Article GET IT
Times cited: 21
Prognostic factors in metastatic germ cell tumors. Progress in clinical and biological research. 1990 Conference Paper GET IT
Times cited: 11
Leukemic differentiation of a mediastinal germ cell tumor. 1989 GET IT
Times cited: 100
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. British journal of urology. 1989 Academic Article GET IT
Times cited: 102
Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program. European journal of cancer & clinical oncology. 1989 Academic Article GET IT
Times cited: 7
Hormone-secreting metastatic interstitial cell tumor of the testis. 1989 GET IT
Times cited: 28
Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors. Cancer. 1989 Academic Article GET IT
Times cited: 41
Systemic chemotherapy in the management of bladder cancer. Cancer treatment and research. 1989 Review GET IT
Times cited: 2
Blood group-related antigens in human germ cell tumors. Cancer research. 1988 Academic Article GET IT
Times cited: 26
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 Academic Article GET IT
Times cited: 216
Identification and management of poor risk patients with germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. Seminars in oncology. 1988 Academic Article GET IT
Times cited: 25
Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 Academic Article GET IT
Times cited: 113
Advanced seminoma: the role of chemotherapy and adjunctive surgery. Annals of internal medicine. 1988 Academic Article GET IT
Times cited: 79
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer. Cancer research. 1988 Academic Article GET IT
Times cited: 20
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. The Journal of urology. 1988 Academic Article GET IT
Times cited: 186
Advances in testicular cancer--role of chemotherapy. Progress in clinical and biological research. 1988 Review GET IT
Times cited: 4
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy. Progress in clinical and biological research. 1988 Review GET IT
New strategies for avoiding total laryngectomy in patients with head and neck cancer. NCI monographs : a publication of the National Cancer Institute. 1988 Academic Article GET IT
Times cited: 12
Phase I trial of escalating doses of cisplatin in hypertonic saline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 30
Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 22
Abnormal colony formation and prostaglandin E responsiveness of myeloid progenitor cells in patients cured of germ cell neoplasms after combination chemotherapy. Cancer. 1987 Academic Article GET IT
Times cited: 4
Hemorrhage: a complication of metastatic testicular choriocarcinoma. 1987 GET IT
Times cited: 37
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 119
Residual mass after chemotherapy for seminoma: changing concepts of management. 1987 GET IT
Times cited: 23
Acute chest pain syndrome during bleomycin infusions. Cancer. 1987 Academic Article GET IT
Times cited: 40
Chemotherapy for germ cell tumors. The Urologic clinics of North America. 1987 Review GET IT
Times cited: 12
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 58
Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours. International journal of andrology. 1987 Academic Article GET IT
Times cited: 2
An analysis of poor risk assignment in patients with germ cell tumours. International journal of andrology. 1987 Academic Article GET IT
Times cited: 1
Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 30
Pituitary and testicular hormonal function after treatment for germ cell tumours. International journal of andrology. 1987 Academic Article GET IT
Times cited: 11
Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin. Breast cancer research and treatment. 1987 Academic Article GET IT
Times cited: 21
Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
Times cited: 43
Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline. Cancer research. 1986 Academic Article GET IT
Times cited: 37
Argument in favor of using mass units to calibrate and report concentrations of human choriogonadotropin. Clinical chemistry. 1986 Letter GET IT
Times cited: 8
Gonadal dysfunction in patients treated for metastatic germ-cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
Times cited: 49
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
Times cited: 166
A pilot study of cisplatin-vinblastine as the initial treatment of advanced head and neck cancer. Cancer. 1986 Academic Article GET IT
Times cited: 13
Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors. Cancer. 1986 Academic Article GET IT
Times cited: 61
Phase 1 trial of levonantradol in chemotherapy-induced emesis. American journal of clinical oncology. 1985 Academic Article GET IT
Times cited: 14
Teratoma with malignant transformation in germ cell tumors in men. 1985 GET IT
Times cited: 182
The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1985 Academic Article GET IT
Times cited: 59
Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 4
Phase II trial of mitoguazone in patients with refractory germ cell tumors. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 4
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors. The American journal of medicine. 1985 Academic Article GET IT
Times cited: 40
VAB-6 as initial treatment of patients with advanced seminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1985 Academic Article GET IT
Times cited: 43
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer. 1985 Academic Article GET IT
Times cited: 181
Chemotherapy trials in recurrent primary intracranial germ cell tumors. Journal of neuro-oncology. 1985 Academic Article GET IT
Times cited: 63
Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center. Acta urologica Belgica. 1985 Review GET IT
Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin. Cancer treatment reports. 1985 Academic Article GET IT
Times cited: 12
Adjuvant surgery in the management of patients with germ cell tumors. The Annals of thoracic surgery. 1984 Editorial Article GET IT
Times cited: 4
Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors. Cancer treatment reports. 1984 Academic Article GET IT
Times cited: 18
Phase II trial of mitoguazone in patients with advanced head and neck cancer. Cancer treatment reports. 1984 Academic Article GET IT
Times cited: 4
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors. American journal of clinical oncology. 1984 Academic Article GET IT
Times cited: 22
The treatment of extragonadal seminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1984 Academic Article GET IT
Times cited: 56
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1984 Academic Article GET IT
Times cited: 59
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy. Annals of clinical and laboratory science. 1984 Academic Article GET IT
Times cited: 6
Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer research. 1983 Academic Article GET IT
Times cited: 233
Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience. The American journal of medicine. 1983 Academic Article GET IT
Times cited: 57
Impact of symptomatic interval on prognosis of patients with stage III testicular cancer. Urology. 1983 Academic Article GET IT
Times cited: 19
Interrelationships of histopathology and other clinical variables in patients with germ cell tumors of the testis. Cancer. 1983 Academic Article GET IT
Times cited: 9
Adjuvant chemotherapy in the management of stage III and IV tumors of the head and neck. CA: a cancer journal for clinicians. 1983 Academic Article GET IT
Times cited: 2
Tumor classification and size in germ-cell testicular cancer: influence on the occurrence of metastases. Cancer. 1982 Academic Article GET IT
Times cited: 23
Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet (London, England). 1981 Academic Article GET IT
Times cited: 122
Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Annals of internal medicine. 1981 Academic Article GET IT
Times cited: 211
Tumor markers in advanced nonseminomatous testicular cancer. Cancer. 1981 Academic Article GET IT
Times cited: 43
Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer. Cancer. 1981 Academic Article GET IT
Times cited: 35
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma. 1980 GET IT
Times cited: 62
Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia. Cancer. 1980 Academic Article GET IT
Times cited: 33
Neuroendocrine (Merkel cell) carcinoma of the skin. A histologic and ultrastructural study of two cases. 1980 GET IT
Times cited: 146
Vinblastine, bleomycin and cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma. Possible importance of longer induction and shorter maintenance schedules. The American journal of medicine. 1980 Academic Article GET IT
Times cited: 58
Acclerated growth of testicular cancer after cytoreductive surgery. 1980 GET IT
Times cited: 83
Sporothrix schenckii meningitis in a farmer with Hodgkin's disease. 1980 GET IT
Times cited: 25
Malignant carcinoid of the gallbladder: third reported case and review of the literature. Journal of surgical oncology. 1980 Review GET IT
Times cited: 22
Prognostic factors in cancer of the testis: an approach to identification. Cancer treatment reports. 1980 Academic Article GET IT
Times cited: 3
Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer. Cancer treatment reports. 1980 Academic Article GET IT
Times cited: 7
Well-differentiated peripheral cholangiocarcinoma with an unusual clinical course. 1979 GET IT
Times cited: 17
Chorionic gonadotrophin and alpha-fetoprotein markers for testicular cancer. Minnesota medicine. 1979 Academic Article GET IT
Intravascular coagulation. Minnesota medicine. 1979 Academic Article GET IT

more ...

less ...

Background

education and training

M.D., Creighton University School of Medicine 1973
B.S., John Carroll University 1969

Contact

full name

George Bosl

VIVO Weill Cornell Medical College

George Bosl Professor Emeritus of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name